Explore

Trendline Trendline
Kessler Topaz Meltzer Check, LLP Urges Soleno Therapeutics Investors to Join Class Action Lawsuit

Kessler Topaz Meltzer Check, LLP Urges Soleno Therapeutics Investors to Join Class Action Lawsuit

Kessler Topaz Meltzer Check, LLP Urges Soleno Therapeutics Investors to Join Class Action Lawsuit
Trendline Trendline
Rosen Law Firm Files Class Action Against Aldeyra Therapeutics Over Misleading Statements

Rosen Law Firm Files Class Action Against Aldeyra Therapeutics Over Misleading Statements

Rosen Law Firm Files Class Action Against Aldeyra Therapeutics Over Misleading Statements
Trendline Trendline
Faruqi Faruqi, LLP Alerts Ultragenyx Pharmaceutical Investors of Securities Class Action Deadline

Faruqi Faruqi, LLP Alerts Ultragenyx Pharmaceutical Investors of Securities Class Action Deadline

Faruqi Faruqi, LLP Alerts Ultragenyx Pharmaceutical Investors of Securities Class Action Deadline
Trendline Trendline
Kessler Topaz Meltzer Check, LLP Files Securities Fraud Lawsuit Against Soleno Therapeutics

Kessler Topaz Meltzer Check, LLP Files Securities Fraud Lawsuit Against Soleno Therapeutics

Kessler Topaz Meltzer Check, LLP Files Securities Fraud Lawsuit Against Soleno Therapeutics
Trendline Trendline
API's Strategic Approach to Drug Development Aims to Overcome 'Valley of Death'

API's Strategic Approach to Drug Development Aims to Overcome 'Valley of Death'

API's Strategic Approach to Drug Development Aims to Overcome 'Valley of Death'
Trendline Trendline
Eli Lilly Faces Price Competition After FDA Approval of Oral Obesity Drug

Eli Lilly Faces Price Competition After FDA Approval of Oral Obesity Drug

Eli Lilly Faces Price Competition After FDA Approval of Oral Obesity Drug
Trendline Trendline
Immunovant's Drug for Thyroid Eye Disease Fails in Pivotal Trials

Immunovant's Drug for Thyroid Eye Disease Fails in Pivotal Trials

Immunovant's Drug for Thyroid Eye Disease Fails in Pivotal Trials
Trendline Trendline
Immunovant's Batoclimab Fails Phase 3 Trials, Impacting Thyroid Eye Disease Treatment Plans

Immunovant's Batoclimab Fails Phase 3 Trials, Impacting Thyroid Eye Disease Treatment Plans

Immunovant's Batoclimab Fails Phase 3 Trials, Impacting Thyroid Eye Disease Treatment Plans
Trendline Trendline
Pharmaceutical Companies Engage in Record M Activity Amid Challenging Environment

Pharmaceutical Companies Engage in Record M Activity Amid Challenging Environment

Pharmaceutical Companies Engage in Record M Activity Amid Challenging Environment
Trendline Trendline
Pharma M Activity Surges with Record Highs Anticipated in 2026

Pharma M Activity Surges with Record Highs Anticipated in 2026

Pharma M Activity Surges with Record Highs Anticipated in 2026
Trendline Trendline
Rosen Law Firm Investigates Immutep Ltd. for Potential Securities Class Action

Rosen Law Firm Investigates Immutep Ltd. for Potential Securities Class Action

Rosen Law Firm Investigates Immutep Ltd. for Potential Securities Class Action
Trendline Trendline
Alto Neuroscience's ALTO-101 Shows Mixed Results in Phase 2 Study for Cognitive Impairment

Alto Neuroscience's ALTO-101 Shows Mixed Results in Phase 2 Study for Cognitive Impairment

Alto Neuroscience's ALTO-101 Shows Mixed Results in Phase 2 Study for Cognitive Impairment